S100A9 and colorectal cancer: S100A9 is highly expressed in exosomes derived from PMN-MDSCs, and its blockade suppresses the stemness of colorectal cancer cells while reducing the susceptibility of mice to azoxymethane/dextran sulfate sodium-induced colitis-associated colon cancer (57).